Sandesh Mahatme - Net Worth and Insider Trading
Sandesh Mahatme Net Worth
The estimated net worth of Sandesh Mahatme is at least $5 Million dollars as of 2024-04-18. Sandesh Mahatme is the EVP, CFO & CBO of Sarepta Therapeutics Inc and owns about 42,191 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $5 Million. Details can be seen in Sandesh Mahatme's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sandesh Mahatme has not made any transactions after 2019-12-13 and currently still holds the listed stock(s).
Transaction Summary of Sandesh Mahatme
Sandesh Mahatme Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandesh Mahatme owns 3 companies in total, including Flexion Therapeutics Inc () , Spyre Therapeutics Inc () , and Sarepta Therapeutics Inc () .
Click here to see the complete history of Sandesh Mahatme’s form 4 insider trades.
Insider Ownership Summary of Sandesh Mahatme
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Flexion Therapeutics Inc | 2020-06-10 | director | |
| Spyre Therapeutics Inc | 2016-04-06 | director | |
| Sarepta Therapeutics Inc | 2019-12-13 | Senior Vice President & CFO |
Sandesh Mahatme Latest Holdings Summary
Sandesh Mahatme currently owns a total of 1 stock. Sandesh Mahatme owns 42,191 shares of Sarepta Therapeutics Inc (SRPT) as of December 13, 2019, with a value of $5 Million.
Latest Holdings of Sandesh Mahatme
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2019-12-13 | 42,191 | 117.83 | 4,971,366 |
Holding Weightings of Sandesh Mahatme
Sandesh Mahatme Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandesh Mahatme has made a total of 1 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 125,000 shares on December 13, 2019, which brought Sandesh Mahatme around $16 Million.
Insider Trading History of Sandesh Mahatme
- 1
Sandesh Mahatme Trading Performance
GuruFocus tracks the stock performance after each of Sandesh Mahatme's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandesh Mahatme is -53.65%. GuruFocus also compares Sandesh Mahatme's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandesh Mahatme within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sandesh Mahatme's insider trading performs compared to the benchmark.
Performance of Sandesh Mahatme
Average Relative Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 34.06 | -53.65 | -14.67 | -32.76 | 3.08 | -7.4 |
| Relative Return to S&P 500(%) | 30.58 | -61.46 | -26.01 | -52.98 | -7.92 | -17.14 |
Sandesh Mahatme Ownership Network
Ownership Network List of Sandesh Mahatme
Ownership Network Relation of Sandesh Mahatme
Sandesh Mahatme Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
Sandesh Mahatme is the director of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , General Counsel Mark S. Levine , and Chief Strategy Officer Christina Willwerth .
Flexion Therapeutics Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
Sandesh Mahatme Mailing Address
Above is the net worth, insider trading, and ownership report for Sandesh Mahatme. You might contact Sandesh Mahatme via mailing address: C/o Celgene Corporation, 86 Morris Avenue, Summit Nj 07901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
